Internal Medicine Doctors in Washington D.c., DC Accepting Medicare
3 Internal Medicine doctors found. Showing 1 - 3
 Dr. Robert P. Williams, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 1140 Varnum Street N.e, Suite 201, Washington D.c., DC 20017 Phone: 202-529-4535 Fax: 202-635-4247 |
 Dr. Unmi Ko Kim, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 50 Irving Street, N.w., Washington D.c., DC 20422 Phone: 202-745-8377 |
Dr. Harvey Washington, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 50 Irving St N.w., Va Medical Center, Washington D.c., DC 20912 Phone: 202-745-8000 |
News Archive
Federal officials ask judge to order upgrade of Georgia's mental health system; VA. officials in court today on suit against health law
Atlanta Journal Constitution: "Talks to settle a federal investigation of Georgia's mental health system came down to a single meeting Wednesday." And, "the talks failed. Federal authorities immediately went to court, asking a judge to force Georgia to make substantial and potentially expensive improvements in its state psychiatric hospitals and in its community-based treatment services — the same measures state officials rejected during the negotiations.
Plant-based omega-3 polyunsaturated fatty acids may have a protective effect on bone health
Normally, most of the omega-3 fatty acids in the diet are plant-derived and come mainly from soybean and canola oil. Other sources are flaxseed, flaxseed oil, walnuts and walnut oil.
Only one-fifth of RA patients had overall adherence rate to prescribed oral medications, study finds
A new study conducted in an ethnically diverse and predominantly low income population found that only one-fifth of rheumatoid arthritis patients had an overall adherence rate to prescribed oral medications at 80% or greater.
FDA decides to review information on Avastin for advanced HER2-negative breast cancer
Genentech, Inc., a member of the Roche Group, today announced that information submitted by the company to the U.S. Food and Drug Administration (FDA) during the review of the supplemental Biologics License Applications (sBLAs) for Avastin (bevacizumab) for previously untreated (first-line) advanced HER2-negative breast cancer has been deemed a major amendment.
› Verified 7 days ago